Tag: Beam Therapeutics

May 31, 2019 Off

Beam Therapeutics, Bio Palette in license agreements for base editing technologies

Beam Therapeutics and Bio Palette today announced an exclusive
cross-license agreement around each companies’ base editing intellectual
property.

April 29, 2019 Off

Beam Therapeutics Presents Data on Multiplex Base Editing for Engineered CAR-T Cells at American Society of Gene and Cell Therapy 22nd Annual Meeting

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Beam Therapeutics, a biotechnology company developing precision genetic medicines through base editing, today announced the presentation of preclinical…